Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PCOS skin symptoms need personalized treatment and psychological support to improve quality of life.

Alopecia is common in severe cases of autosomal recessive congenital ichthyosis.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

Botulinum toxin was found to be a safe and effective treatment for male pattern baldness in a small test, but more research is needed.

More people are using Google to search for skin problems like itch, hair loss, and rashes.

Using hair follicles can improve skin drug delivery.

TrichoTech™ may help hair growth and skin repair by increasing fibroblast growth and activity.

A new AI model diagnoses hair and scalp disorders with 92% accuracy, better than previous models.

Patients with chronic skin disorders often experience depression, anxiety, and reduced quality of life and may benefit from psychiatric help.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Effective PCOS management needs clear roles between primary and specialist care, digital tools, and patient education.

Camellia oleifera leaves have compounds beneficial for cosmetics and medicine.

Hair loss in Saudi Arabia causes a low psychosocial impact, with less effect on those without a family history of hair loss.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

Research on the human skin microbiome has grown, focusing on skin health and diseases, with more studies needed on antibiotic resistance and AI applications.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

COVID-19 can cause long-lasting non-respiratory symptoms, especially in women.

Treating underlying metabolic and hormonal issues is key to managing female hair loss.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

The laser therapy device effectively increased hair growth in people with androgenetic alopecia.

Dermatology residents need better training to treat hair conditions in patients with skin of color.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

The journal is essential for dermatologic surgery professionals.

More research is needed to confirm effective hair loss treatments.